Meeting
2022 ASCO Genitourinary Cancers Symposium
Recurrence patterns in bladder cancer patients with no residual disease (pT0N0) at radical cystectomy.
Authors
Seyedeh Sanam Ladi Seyedian
USC Institute of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
Seyedeh Sanam Ladi Seyedian , Antoin Douglawi , Ryan Lee , Muhannad Alsyouf , Alireza Ghoreifi , Sumeet Bhanvadia , Anne K. Schuckman , Hooman Djaladat , Siamak Daneshmand
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Other
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 576)
DOI
10.1200/JCO.2022.40.6_suppl.576
Abstract #
576
Poster Bd #
L4
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Outcomes and survival in nonbilharzial pure squamous cell bladder cancer in patients undergoing curative radical cystectomy.
First Author: Janet Baack Kukreja
Poster
2024 ASCO Genitourinary Cancers Symposium
Impact of intraoperative tranexamic acid use on overall survival and cancer specific survival in patients undergoing radical cystectomy.
First Author: Mohamed E. Ahmed
Poster
2023 ASCO Genitourinary Cancers Symposium
Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC).
First Author: Andrew B Katims
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival outcomes with radical cystectomy (RC) in localized clinically node-positive bladder cancer (CNBC).
First Author: Stuthi Perimbeti